ARATINGA BIO TNP has a total of 13 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are PU-LIKE BIO-ENGINEERING CO LTD, HOBDEN ADRIAN and TARGOVAX OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Vaillant Renaud | 12 |
#2 | Bishop Philippe | 11 |
#3 | Bauche Cecile | 10 |
#4 | Mourlane Frederic | 9 |
#5 | Sarry Emeline | 7 |
#6 | Miodek Anna | 4 |
#7 | Mourlane Frédéric | 3 |
#8 | Bauche Cécile | 2 |
#9 | Frederic Mourlane | 1 |
#10 | Philippe Bishop | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021053400A2 | Dmso-free synthesis of oligopeptide-modified poly(beta-amino ester)s and their use in nanoparticle delivery systems | |
WO2021019297A1 | Aptamer-based multispecific therapeutic agents | |
AU2019309328A1 | Aptamer-based CAR T-cell switch | |
KR20200128520A | Polymer-encapsulated viral vectors for gene therapy |